BACKGROUND Understanding the knowledge, perception and attitudes towards Ebola vaccines is an important factor in ensuring future use of these vaccines. A qualitative methods study e...
Gelormini M, Gripenberg M, Marke D, Murray MB, Yambasu S, et al.
2023-03-03 • Vaccine
2023-03-03 • Vaccine
Background: On 14 August 2017, massive landslides and floods hit Freetown (Sierra Leone). More than 1,000 people lost their lives while approximately 6,000 people were displaced. The are...
Urrunaga-Pastor D, Herrera-Anazco P, Uyen-Cateriano A, Toro-Huamanchumo CJ, Rodriguez-Morales AJ, et al.
2021-11-09 • Vaccine
2021-11-09 • Vaccine
We aimed to estimate the prevalence and factors associated with parents' non-intention to vaccinate their children and adolescents against COVID-19 in Latin America and the Caribbean (LA...
Hoeve CE, Gadroen K, Kwa MSG, van Haren A, Sturkenboom MCJM, et al.
2020-03-01 • Vaccine
2020-03-01 • Vaccine
BACKGROUND Serious adverse reactions after immunization are rare but do occur. In very rare instances, cases with fatal outcome have been reported. These reports can have a huge impa...
Cavailler P, Perroud V, Mcchesney M, Ampuero S, Guerin PJ, et al.
2006-05-29 • Vaccine
2006-05-29 • Vaccine
We conducted a study to assess the feasibility and the potential vaccine coverage of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban endemic neighbourhood o...
Lightowler M, Manangazira P, Nackers F, Van Herp M, Phiri I, et al.
2022-06-09 • Vaccine
2022-06-09 • Vaccine
BACKGROUND Zimbabwe suffers from regular outbreaks of typhoid fever (TF), worse since 2017. Most cases were in Harare and a vaccination campaign with Typhoid Conjugate Vaccine (TCV) ...
Huhn GD, Brown J, Perea W, Berthe A, Otero H, et al.
2006-02-06 • Vaccine
2006-02-06 • Vaccine
Yellow fever (YF) is a mosquito-borne vaccine-preventable disease with high mortality. In West Africa, low population immunity increases the risk of epidemic transmission. A cluster surv...
Juan-Giner A, Alsalhani A, Panunzi I, Lambert V, Van Herp M, et al.
2020-02-08 • Vaccine
2020-02-08 • Vaccine
Measles outbreaks occur periodically in remote and difficult to reach areas in countries such as the Democratic Republic of Congo. The possibility to keep measles vaccines at temperature...
Nackers F, Cohuet S, le Polain de Waroux O, Langendorf C, Nyehangane D, et al.
2017-09-18 • Vaccine
2017-09-18 • Vaccine
BACKGROUND Information on Streptococcus pneumoniae nasopharyngeal (NP) carriage before the pneumococcal conjugate vaccine (PCV) introduction is essential to monitor impact. The 10-va...
Juan-Giner A, Domicent C, Langendorf C, Roper M, Baoundoh P, et al.
2014-09-23 • Vaccine
2014-09-23 • Vaccine
In resource-poor settings, cold chain requirements present barriers for vaccine delivery. We evaluated the immunogenicity and safety of tetanus toxoid (TT) vaccine in "Controlled Tempera...
Poncin M, Marembo J, Chitando P, Sreenivasan N, Makwara I, et al.
2022-08-02 • Vaccine
2022-08-02 • Vaccine
INTRODUCTION Typhoid fever is a public-health problem in Harare, the capital city of Zimbabwe, with seasonal outbreaks occurring annually since 2010. In 2019, the Ministry of Health ...
Juan-Giner A, Hitchings MD, Soumah A, Strecker T, Sadjo M, et al.
2020-06-01 • Vaccine
2020-06-01 • Vaccine
Background
As part of a Phase III trial with the Ebola vaccine rVSVΔG-ZEBOV-GP in Guinea, we invited frontline workers (FLWs) to participate in a sub-study to provide additional inf...
Nongovernmental organisations (NGOs) are the main actors of vaccine delivery during complex humanitarian emergencies such as large population displacements. This paper discusses the use ...
Simon JK, Kennedy SB, Mahon BE, Dubey SA, Grant-Klein RJ, et al.
2022-10-05 • Vaccine
2022-10-05 • Vaccine
BACKGROUND ERVEBO®, a live recombinant vesicular stomatitis virus (VSV) vaccine containing the Zaire ebolavirus glycoprotein (GP) in place of the VSV GP (rVSVΔG-ZEBOV-GP), was advanc...
Laboratory diagnosis is an essential component in surveillance of meningococcal epidemics, as it can inform decision-makers of the Neisseria meningitidis serogroup(s) involved and the mo...
Analysis of immunogenicity data is a critical component of vaccine development, providing a biological basis to support any observed protection from vaccination. Conventional methods for...
Grantz KH, Claudot P, Kambala M, Kouyate M, Soumah A, et al.
2019-11-15 • Vaccine
2019-11-15 • Vaccine
BACKGROUND Alongside the clinical aspects of the immunogenicity and safety trial of an Ebola vaccine deployed among front-line workers, a qualitative study was conducted to describe ...
BACKGROUND:
During a measles epidemic, the Ministry of Public Health (MOH) of the Democratic Republic of the Congo conducted supplementary immunization activities (2016-SIA) from Au...
van Zandvoort K, Checchi F, Diggle E, Eggo RM, Gadroen K, et al.
2019-10-23 • Vaccine
2019-10-23 • Vaccine
Streptococcus pneumoniae is a common human commensal that causes a sizeable part of the overall childhood mortality in low income settings. Populations affected by humanitarian crises ar...
Coldiron ME, Guindo O, Makarimi R, Soumana I, Matar Seck A, et al.
2018-05-08 • Vaccine
2018-05-08 • Vaccine
BACKGROUND Rotavirus remains a major cause of diarrhea among children under 5 years of age. The efficacy of RotaSIIL, a pentavalent rotavirus vaccine, was shown in an event-driven tr...
